Janus Henderson Group plc 13D and 13G filings for Biohaven Pharmaceutical Holding Company Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:23 pm Purchase |
2024-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
JANUS HENDERSON GROUP PLC JHG |
6,982,425 6.900% |
756,032 (+12.14%) |
Filing |
| 2024-11-14 3:06 pm Purchase |
2024-09-30 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
JANUS HENDERSON GROUP PLC JHG |
6,226,393 6.600% |
325,050 (+5.51%) |
Filing |
| 2024-02-13 12:47 pm Purchase |
2023-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
JANUS HENDERSON GROUP PLC JHG |
5,901,343 7.400% |
1,338,832 (+29.34%) |
Filing |
| 2023-02-13 10:14 am Purchase |
2022-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
JANUS HENDERSON GROUP PLC JHG |
4,562,511 6.700% |
4,562,511 (New Position) |
Filing |